David Koos

David Raymond Koos was the founder of Entest Group, Inc., founded in 2008, where the titles held included Chairman, President, CEO, CFO & Secretary from 2009 to 2018.
Current jobs include Chairman, President, CEO, CFO & Secretary at Regen Biopharma, Inc. since 2012; Chairman, President, CEO, Secretary & Treasurer at Kcl Therapeutics, Inc. since 2021; Chairman & Chief Executive Officer at BST Partners, Inc. since 2018; President & Managing Director at Venture Bridge, Inc. since 2001; President, Managing Director & Director at Cell Source Research, Inc. since 2003; Trustee at BMXP Holdings Shareholders Business Trust; and Trustee at AFN Trust.
Former jobs include President & Chief Executive Officer at Tasco Holdings International, Inc. in 2006; Chairman, Chief Executive Officer, CFO & Secretary at Frezer, Inc. from 2005 to 2007; President, CEO, CFO, Secretary & CAO at JB Clothing Corp.
in 2009; Chairman, CEO & Acting Chief Financial Officer at BMXP Holdings, Inc. from 2004 to 2008; Chairman, President, CEO, CFO & Secretary at Rivulet Media, Inc. from 2006 to 2019; Chairman & Chief Executive Officer at Freedom Environmental Services, Inc.; Chairman & Chief Executive Officer at BEFUT International Co. Ltd.; Chairman, President, CEO, CFO & Secretary at Entest BioMedical, Inc.; Chairman & Chief Executive Officer at Zander Therapeutics, Inc. from 2017 to 2020; Chairman, President, CEO, Secretary & Treasurer at SYBLEU, Inc. from 2020 to 2022; Chairman & Chief Executive Officer at BST Partners, Inc. (Wyoming); and Chairman, Chief Financial Officer & Secretary at Cell Bio-Systems, Inc. in 2003.
Education includes a graduate degree from the University of California, Riverside in 1983 and a doctorate from Atlantic International University in 2003.